Herbas VPB

Print
EN | LT
LT - Rapamicino analogai, sujungti su C40-, C28- IR C32-, kaip MTOR inhibitoriai
EN - C40-, C28-, AND C-32-LINKED RAPAMYCIN ANALOGS AS MTOR INHIBITORS

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 498/18 (2006.01)
C07D 519/00 (2006.01)
A61P 35/00 (2006.01)
European patent
(11) Number of the document 3788049
(13) Kind of document T
(96) European patent application number 19723571.6
Date of filing the European patent application 2019-04-29
(97) Date of publication of the European application 2021-03-10
(45) Date of publication and mention of the grant of the patent 2023-03-29
(46) Date of publication of the claims translation 2023-07-25
PCT application
(86) Number PCT/US2019/029737
Date 2019-04-29
PCT application publication
(87) Number WO 2019/212990
Date 2019-11-07
Priority applications
(30) Number Date Country code
201862665435 P 2018-05-01 US
201862752874 P 2018-10-30 US
201962836036 P 2019-04-18 US
Inventors
(72)
PITZEN, Jennifer , US
GLIEDT, Micah James Evans , US
BURNETT, G. Leslie , US
AGGEN, James Bradley , US
KISS, Gert , US
CREGG, James Joseph , US
SEMKO, Christopher Michael , US
WON, Walter , US
WANG, Gang , US
LEE, Julie Chu-Li , US
THOTTUMKARA, Arun P. , US
GILL, Adrian Liam , US
MELLEM, Kevin T. , US
Grantee
(73) Revolution Medicines, Inc. , 700 Saginaw Drive, Redwood City, CA 94063, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Rapamicino analogai, sujungti su C40-, C28- IR C32-, kaip MTOR inhibitoriai
  C40-, C28-, AND C-32-LINKED RAPAMYCIN ANALOGS AS MTOR INHIBITORS
Last renewal fee
Payment date Validity (years) Amount
2025-03-24 7 162.00 EUR
Next renewal fee
2026-04-29